Severe periodontitis is associated with the serum levels of hypersensitive C reactive protein and lipoprotein-associated phospholipase A2 in the patients of acute ischemic stroke

2021 ◽  
Vol 88 ◽  
pp. 232-236
Author(s):  
Chunchun Chen ◽  
Jinhua Zhu ◽  
Xuhui Deng ◽  
Zhi Yang ◽  
Weifeng Lin ◽  
...  
2011 ◽  
Vol 259 (2) ◽  
pp. 400-400 ◽  
Author(s):  
Heidi Ormstad ◽  
Hans Christian Dalsbotten Aass ◽  
Niels Lund-Sørensen ◽  
Karl-Friedrich Amthor ◽  
Leif Sandvik

2014 ◽  
pp. 1451 ◽  
Author(s):  
Hasan Kara ◽  
Murat Akinci ◽  
Selim Degirmenci ◽  
Aysegul Bayir ◽  
Ahmet Ak ◽  
...  

2011 ◽  
Vol 258 (4) ◽  
pp. 677-685 ◽  
Author(s):  
Heidi Ormstad ◽  
Hans Christian Dalsbotten Aass ◽  
Niels Lund-Sørensen ◽  
Karl-Friedrich Amthor ◽  
Leif Sandvik

2010 ◽  
Vol 29 (4) ◽  
pp. 372-375 ◽  
Author(s):  
Heleen M. den Hertog ◽  
Evita G. van den Herik ◽  
Diederik W.J. Dippel ◽  
Peter J. Koudstaal ◽  
Moniek P.M. de Maat

2020 ◽  
Vol 17 ◽  
Author(s):  
Shiling Chen ◽  
Chao Pan ◽  
Ping Zhang ◽  
Yingxin Tang ◽  
Zhouping Tang

Abstract:: Acute Ischemic Stroke (AIS) is currently the most frequently reported neurological complication of Coronavirus disease 2019 (COVID-19). This article will elaborate on the clinical features of inpatients with COVID-19 and AIS and the pathophysiological mechanism of AIS under the background of COVID-19. Through a detailed search of relevant studies, we found that the incidence of AIS among COVID-19 patients varied from 0.9% to 4.6%, and AIS has been observed in many people without underlying diseases and cardiovascular risk factors as well as young people. The National Institute of Health Stroke Scale (NIHSS) score of COVID-19 patients with AIS was higher than historical AIS patients, and the proportion of large vessel occlusion (LVO) was about 64.2%. COVID-19 patients with AIS have commonly high levels of D-D dimer, fibrinogen, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR), suggesting systemic hyperinflammatory and hypercoagulable state. The pooled mortality of COVID-19 patients with AIS was 38% and the mortality of LVO patients is higher (45.9%). Compared with COVID-19-negative AIS patients in the same period in 2020 and 2019, COVID- 19 patients with AIS had a worse prognosis.


Sign in / Sign up

Export Citation Format

Share Document